48
Participants
Start Date
December 15, 2021
Primary Completion Date
September 1, 2026
Study Completion Date
September 1, 2027
Teriparatide
20 micrograms
DXA,VFA, X-ray, HR-pQCT, 18-F NAF PET/CT
All participants undergo DXA and VFA or X-ray scans 3 times during the study. Some participants (those connected to Herlev) are offered 18F NAF PET/CT scans at baseline and after 12 months and some participants (those connected to Odense University Hospital and Aalborg University Hospital) are offered HR-pQCT scans at baseline and after 12 months. The 18F-NAF PET/CT and HR-pQCT are optional, so it is not a must to have these procedures done to participate in the study.
Bone biopsy
All participants are invited to undergo a bone biopsy after 12 months, but it is not a must to have the procedure done to participate in the study.
Cardiac tests
All participants are invited to undergo 24-hour blood pressure measurements and pulse wave measurements at baseline and after 18 months, but it is not a must to have these procedures done to participate in the study.
Blood and urine samples and physical examination
All participants must undergo a physical examination and deliver blood and urine samples in order to participate in the study.
RECRUITING
Herlev and Gentofte Hospital, Herlev Hospital, Herlev
NOT_YET_RECRUITING
Steno Diabetes Center Copenhagen, Gentofte Municipality
NOT_YET_RECRUITING
Odense University Hospital, Odense
NOT_YET_RECRUITING
Aalborg University Hospital, Aalborg
Odense University Hospital
OTHER
Steno Diabetes Center Copenhagen
OTHER
Rigshospitalet, Denmark
OTHER
Aalborg University Hospital
OTHER
Ditte Hansen
OTHER